Why is Jagsonpal Pharma falling/rising?

As of 24-Sep, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 235.00, which reflects a decrease of Rs 6.85 or 2.83%. The stock has underperformed its sector by 2.38% today, touching an intraday low of Rs 234.8. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 3.49%, while it has shown a slight decline of 0.13% over the past month. Despite a strong long-term performance, with a 42.42% increase over the past year, recent investor participation has fallen, as evidenced by a 28.81% drop in delivery volume compared to the 5-day average.
In the broader market context, the Sensex has only declined by 1.18% over the past week, suggesting that Jagsonpal Pharmaceuticals is underperforming relative to the benchmark. While the company has demonstrated healthy growth metrics, such as a 54.58% increase in profit after tax over the last six months and a strong debtors turnover ratio, these positive factors have not been sufficient to counteract the recent downward pressure on the stock price. The overall market sentiment appears to be affecting investor confidence, leading to the current decline in Jagsonpal Pharmaceuticals' stock value.